Recent research conducted by teams from Edith Cowan University (ECU), Curtin University, and the University of Western Australia has provided significant insights into the relationship between calcium supplementation and dementia risk. This study, detailed in the journal The Lancet Regional Health—Western Pacific, addresses previous concerns about the cognitive health implications of calcium supplements in older women, particularly those dealing with osteoporosis.

Study Overview

The study involved a rigorous analysis of outcomes from earlier research that monitored 1,460 older women over a five-year period. Participants were either given calcium supplements or a placebo. The core findings suggest that calcium monotherapy does not elevate the risk of developing dementia in this demographic, providing a much-needed sense of reassurance to both patients and healthcare providers.

Importance of Calcium Supplements

Calcium supplements are frequently recommended as a preventative strategy against osteoporosis, a condition that affects approximately 20% of women over the age of 70. Given that osteoporosis increases the risk of fractures, the health community has widely supported calcium supplementation. Ms. Negar Ghasemifard, a Ph.D. student at ECU, stated:

“Calcium supplements are often recommended to prevent or manage osteoporosis. Our study provides reassurance about the safety of these supplements concerning dementia risk in older women.”

Methodology and Long-term Findings

Dr. Marc Sim, a Senior Research Fellow at ECU, highlighted the study's robust methodological design:

  • The research leveraged a post-hoc analysis from a double-blind, placebo-controlled randomized clinical trial. This structure minimizes biases common in observational studies.
  • 730 subjects received calcium supplements over five years, while 730 others were given a placebo, creating a substantial comparison basis.
  • With a follow-up period of 14.5 years, the study assessed long-term outcomes extensively.

Comparative Analysis with Previous Research

Dr. Sim emphasized the uniqueness of their findings compared to past studies, which often lacked rigorous control measures. He stated:

“Earlier research indicating a potential link between calcium supplementation and dementia was largely observational. Our findings present a clearer picture and are less likely to be affected by unmeasured confounding variables.”

Further Research Directions

While the results are promising and suggest no direct correlation between calcium supplements and the risk of dementia in older women, Professor Simon Laws, director of ECU's Center for Precision Health, cautioned that more research is paramount:

  • The applicability of these findings to other demographics, including men or younger women, remains uncertain.
  • Future studies should incorporate both vitamin D alongside calcium to further clarify and substantiate the findings.
  • It is vital to implement robust measures to assess brain health as a primary outcome.

Calcium's Role and Clinical Implications

The research reinforces calcium's essential role in various physiological functions, including maintaining bone health. Professor Blossom Stephan, a Dementia Australia Honorary Medical Advisor, pointed out:

“This research provides critical reassurance regarding the long-term safety of calcium supplementation, validating its role in maintaining bone health without increasing dementia risk in older women.”

Conclusion and Key Takeaways

The comprehensive evaluation of the data leads to several key conclusions:

  • Calcium supplements do not increase the risk of dementia in older women based on a long-term, controlled trial.
  • The study's findings help to dispel lingering doubts about the cognitive safety of calcium supplementation.
  • Researchers advocate for further investigation into the effects of calcium among other populations and the potential synergistic role of vitamin D.

These insights mark an important step forward in the pursuit of effective osteoporosis management strategies that do not compromise cognitive health, reassuring both patients and clinicians in their continued use of calcium supplements.

References

Ghasemifard, N., et al. (2025). Calcium supplementation and the risk of dementia in the Perth Longitudinal Study of Aging Women: a post-hoc analysis of a randomised clinical trial for fracture prevention. The Lancet Regional Health - Western Pacific.

For more detailed insights, please refer to the full article at Medical Xpress.